BBP

Virtus Biotech ETF

101.80

Oct 14 • 3:58 PM ET +1.09 (1.09%)

101.80

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Financial Exchange Traded Fund USA NYSE

Category	US Equities - Industry Sector
Sponsor	Virtus ETF Solutions
Fund Family
Index	LifeSci Biotechnology Products Index
Index Weighting
Active/Passive
Dividend TTM	-
Dividend Ex-Date	Dec 20, 2017
Dividend Gr. 3/5Y	- -
Expense	0.34%
Inverse/Leveraged
IPO	Dec 17, 2014

Asset Type	Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short	Yes / Yes

Tags	U.S.
Tags	equity
Tags	healthcare
Tags	biotechnology
Tags	-
Tags	-
Tags	-
Sector/Theme
Region
SMA20	-1.94%
SMA50	-2.40%
SMA200	11.77%

Return% 1Y	42.24%
Return% 3Y	26.97%
Return% 5Y	15.21%
Return% 10Y
Return% SI
Flows% 1M	4.22%
Flows% 3M	25.72%
Flows% YTD	109.36%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades

Total Holdings	68
AUM	125.93M
NAV/sh
52W High	110.05 -7.50%
52W Low	70.30 44.80%
Volatility	2.37% 2.18%
ATR (14)	2.33
RSI (14)	45.60
Beta	0.58
Rel Volume	1.41
Avg Volume	11.36K
Volume	16,043

Perf Week	-0.01%
Perf Month	0.65%
Perf Quarter	5.03%
Perf Half Y	16.57%
Perf YTD	27.39%
Perf Year	43.36%
Perf 3Y	109.90%
Perf 5Y	100.27%
Perf 10Y	232.36%
Prev Close	100.71
Price	101.80
Change %	1.09%

Mar-09-26 11:03AM	ImmunityBio Announces FDA Resubmission For Expanded Use Of Lead Drug (Benzinga)
Feb-17-26 09:44AM	Why Is ImmunityBio Stock Gaining Tuesday? (Benzinga)
Oct-30-25 09:00AM	Biotech ETFs Hovering Around a 52-Week: Here's Why (Zacks)
Oct-20-25 06:00AM	Biotech ETFs Bounce Back in 2025: Here's Why (Zacks)
May-02-25 03:25AM	Aim To Keep Risk Modest And Quality High (Seeking Alpha)
04:35AM	Loading…
Apr-30-25 04:35AM	3 Ways To Avoid The Eye Of The Equity Market Storm (Seeking Alpha)
Apr-23-25 05:45AM	Rewiring Global Trade For Resilience And Growth (Seeking Alpha)
Apr-18-25 01:40PM	Institutional, Retail Investors Shed $27B In U.S. Stocks In Early April Sell-Off (Seeking Alpha)
Apr-04-25 08:30AM	How Will New Tariffs Impact Your Investment Portfolio In 2025? (Seeking Alpha) -5.80%
Apr-02-25 07:00AM	The Great Transformation: Riding The Wave Of Change (Seeking Alpha)
Apr-01-25 05:40AM	U.S. Consumers To Be Hit Hardest By Pharmaceutical Tariffs (Seeking Alpha)
Mar-29-25 12:50AM	Trade Turbulence And The Tariff-ic Mess For Investors (Seeking Alpha)
Mar-28-25 06:05AM	Volatility Brings Changes To Market Leadership (Seeking Alpha)
Mar-20-25 04:32PM	How ESG Policies Can Keep The Healthcare Sector Fighting Fit (SeekingAlpha)

Virtus LifeSci Biotech Products ETF seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.

open in yahoo | open in marketwatch | open in google

BBP

Virtus Biotech ETF

Upgrade your Finviz experience